BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication. World J Gastroenterol 2015; 21(18): 5568-5574 [PMID: 25987781 DOI: 10.3748/wjg.v21.i18.5568]
URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5568.htm
Number Citing Articles
1
Varocha Mahachai, Ratha‐korn Vilaichone, Rapat Pittayanon, Jarin Rojborwonwitaya, Somchai Leelakusolvong, Monthira Maneerattanaporn, Peranart Chotivitayatarakorn, Sombat Treeprasertsuk, Chomsri Kositchaiwat, Pises Pisespongsa, Pisaln Mairiang, Aziz Rani, Alex Leow, Swe Mon Mya, Yi‐Chia Lee, Sengdao Vannarath, Bouachanh Rasachak, Oung Chakravuth, Moe Myint Aung, Tiing‐Leong Ang, Jose D Sollano, Duc Trong Quach, Inchaya Sansak, Olarn Wiwattanachang, Piyathida Harnsomburana, Ari Fahrial Syam, Yoshio Yamaoka, Kwong‐Ming Fock, Khean‐Lee Goh, Kentaro Sugano, David Graham. Helicobacter pylori management in ASEAN: The Bangkok consensus reportJournal of Gastroenterology and Hepatology 2018; 33(1): 37 doi: 10.1111/jgh.13911
2
Sung Eun Kim, Nayoung Kim, Seon Mee Park, Won Hee Kim, Gwang Ho Baik, Yunju Jo, Kyung Sik Park, Ju Yup Lee, Ki-Nam Shim, Gwang Ha Kim, Bong Eun Lee, Su Jin Hong, Seon-Young Park, Suck Chei Choi, Jung Hwan Oh, Hyun Jin Kim. Female Gender is a Poor Predictive Factor of Functional Dyspepsia Resolution after Helicobacter pylori Eradication: A Prospective, Multi-center Korean TrialThe Korean Journal of Gastroenterology 2018; 72(6): 286 doi: 10.4166/kjg.2018.72.6.286
3
Anthony O'Connor, Wolfgang Fischbach, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2016Helicobacter 2016; 21(S1): 55 doi: 10.1111/hel.12342
4
Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi. The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure inHelicobacter pyloriEradicationThe Korean Journal of Gastroenterology 2017; 70(2): 72 doi: 10.4166/kjg.2017.70.2.72
5
Hideki Mori, Hidekazu Suzuki. Update on quinolone-containing rescue therapies for <i>Helicobacter pylori</i> infectionWorld Journal of Gastroenterology 2020; 26(15): 1733-1744 doi: 10.3748/wjg.v26.i15.1733
6
Xianghong Zhao, Zhongqiu Zhang, Fang Lu, Mengqiu Xiong, Liping Jiang, Ke Tang, Min Fu, Yu Wu, Bangshun He. Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.938419
7
Sumaira Khadim, Iyad Muhammad Naeem, Muhammad Tanveer Alam, Hina Rehman, Sidra Ghayas, Sajjad Haider. The efficacy of moxifloxacin-based triple-therapy in first-line treatment of Helicobacter pylori infection in Pakistan: randomized controlled trialsArchives of Medical Science – Civilization Diseases 2023; 8(1): 31 doi: 10.5114/amscd.2023.131926
8
Amin Talebi Bezmin Abadi. Helicobacter pylori treatment: New perspectives using current experienceJournal of Global Antimicrobial Resistance 2017; 8: 123 doi: 10.1016/j.jgar.2016.11.008
9
Sung Eun Kim, Ji Hun Roh, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Jae Joon Heo. Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication TherapyThe Korean Journal of Gastroenterology 2019; 73(1): 26 doi: 10.4166/kjg.2019.73.1.26